IMDX vs AAPL: Which Stock is Better?
Side-by-side comparison of Insight Molecular Diagnostics Inc and Apple Inc in 2026
IMDX
Insight Molecular Diagnostics Inc
$3.00
AAPL
Apple Inc
$258.66
Key Metrics Comparison
| Metric | IMDX | AAPL | Winner |
|---|---|---|---|
| Market Cap | $101.97M | N/A | IMDX |
| P/E Ratio | N/A | 32.77 | AAPL |
| EPS (TTM) | $N/A | $7.91 | AAPL |
| Revenue Growth | -0.2% | 0.2% | AAPL |
| Gross Margin | 56.8% | 47.3% | IMDX |
Analyze IMDX
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMDX or AAPL a better investment?
Comparing IMDX and AAPL: Insight Molecular Diagnostics Inc has a market cap of $101.97M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMDX and AAPL?
IMDX (Insight Molecular Diagnostics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMDX or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMDX or AAPL?
AAPL has higher revenue growth at 0.2% vs -0.2% for IMDX.
Which company is more profitable: IMDX or AAPL?
Insight Molecular Diagnostics Inc (IMDX) has higher gross margins at 56.8% compared to 47.3% for AAPL.
Which is the larger company: IMDX or AAPL?
Insight Molecular Diagnostics Inc (IMDX) is larger with a market cap of $101.97M compared to N/A for AAPL.
Should I buy IMDX or AAPL in 2026?
Both IMDX and AAPL have investment merit. IMDX trades at $3.00 while AAPL trades at $258.66. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMDX and AAPL stock?
Key differences: Market Cap ($101.97M vs N/A), P/E Ratio (N/A vs 32.8x), Revenue Growth (-0.2% vs 0.2%), Gross Margin (56.8% vs 47.3%).